File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
  • Find via Find It@HKUL
Supplementary

Conference Paper: Hepatitis B surface antigen (HBsAg) reductions following administration of a single dose of VIR-3434, an investigational, neutralizing, vaccinal monoclonal antibody: first experience in participants with high HBsAg burden

TitleHepatitis B surface antigen (HBsAg) reductions following administration of a single dose of VIR-3434, an investigational, neutralizing, vaccinal monoclonal antibody: first experience in participants with high HBsAg burden
Authors
Issue Date31-Mar-2023
PublisherSpringer
Persistent Identifierhttp://hdl.handle.net/10722/337112
ISSN
2021 Impact Factor: 9.029
2020 SCImago Journal Rankings: 1.304

 

DC FieldValueLanguage
dc.contributor.authorYuen, MF-
dc.contributor.authorAgarwal, K-
dc.contributor.authorWedemeyer, H-
dc.contributor.authorCloutier, D-
dc.contributor.authorShen, L-
dc.contributor.authorArizpe, A-
dc.contributor.authorHassani, A-
dc.contributor.authorGupta, SV-
dc.contributor.authorHwang, C-
dc.contributor.authorGane, E-
dc.contributor.authorAgarwal, K-
dc.date.accessioned2024-03-11T10:18:11Z-
dc.date.available2024-03-11T10:18:11Z-
dc.date.issued2023-03-31-
dc.identifier.issn1936-0533-
dc.identifier.urihttp://hdl.handle.net/10722/337112-
dc.languageeng-
dc.publisherSpringer-
dc.relation.ispartofHepatology International-
dc.titleHepatitis B surface antigen (HBsAg) reductions following administration of a single dose of VIR-3434, an investigational, neutralizing, vaccinal monoclonal antibody: first experience in participants with high HBsAg burden-
dc.typeConference_Paper-
dc.identifier.volume17-
dc.identifier.issueS1-
dc.identifier.spageS125-
dc.identifier.eissn1936-0541-
dc.identifier.issnl1936-0533-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats